Sunday 3 January 2021

EyePoint Pharmaceuticals Announces $15.7 Million Equity Investment by Asia Partner Ocumension Therapeutics - GlobeNewswire

EyePoint Pharmaceuticals Announces $15.7 Million Equity Investment by Asia Partner Ocumension Therapeutics  GlobeNewswire

No comments:

Post a Comment